European Antibody Congress 2015 comes to Basel

The European Antibody Congress takes place 9-11 November 2015 at the Congress Centre, Basel. It’s a conference and exhibition featuring new and exciting content focusing on innovation and commercialisation with an emphasis on new platforms and exciting new technologies such as computer aided antibody design.

From huge advances in cancer therapies and immune system modulation, to recent developments in the treatment of Ebola, to a new dengue fever vaccine, antibody based drugs are set to have profound effects in every area of medicine in the very near future. From discovery and development to business modelling, the European Antibody Congress proudly welcomes 600 members of the antibodies, biosimilars and high potency API community to meet and do business in 2015. 

The main conference will include discussions presented by Roche, Novartis, Pfizer and Seattle Genetics as well as C-level executives of smaller innovative biotechs and academics doing cutting edge research.

The floor will include 20+ exhibitors including Catalent, NDA, KBI Biopharma, Forte Bio- a division of Pall Life Sciences and Fujifilm Diosynth Biotechnologies. Dedicated platform technology showcases and poster presentation sessions are also available, demonstrating the newest innovations in technology and research.